epoetin beta [NeoRecormon]
Sponsors
Hoffmann-La Roche
Conditions
AnemiaAnemia, Neoplasms
Phase 3
Phase 4
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
CompletedNCT00377481
Start: 2006-09-30End: 2007-06-30Updated: 2016-11-02
A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.
CompletedNCT00413101
End: 2008-03-31Updated: 2009-05-14
A Study of NeoRecormon in Patients With Chronic Kidney Disease.
CompletedNCT00437723
End: 2008-04-30Updated: 2009-05-14
A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.
TerminatedNCT00440063
Updated: 2007-12-20
A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.
CompletedNCT00560274
Start: 2008-03-31End: 2011-11-30Updated: 2016-02-02
Unknown Phase
An Observational Study of Epoetin Beta [Neorecormon] to Evaluate the Quality of Life in Patients on Dialysis With Chronic Renal Anemia
CompletedNCT01105494
Start: 2008-12-31End: 2012-06-30Updated: 2012-09-13
An Observational Study of NeoRecormon (Epoetin Beta) in Cancer Patients With Anemia (FAST)
CompletedNCT01168349
Start: 2010-01-31End: 2010-12-31Updated: 2015-10-02